middle.news
Integral Diagnostics Surpasses Merger Synergy Targets with 33.7% Revenue Surge
11:25pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Integral Diagnostics Surpasses Merger Synergy Targets with 33.7% Revenue Surge
11:25pm on Friday 29th of August, 2025 AEST
Key Points
33.7% consolidated revenue growth to $628 million
Operating EBITDA rises 38.3% with margin improvement to 20.1%
Merger synergies with Capitol Health exceed initial $10 million target, reaching $14 million annualised
Operating diluted EPS grows 32.9% to 10.2 cents
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Integral Diagnostics (ASX:IDX)
OPEN ARTICLE